Medtronic expands pain management portfolio with $650 million acquisition of SPR Therapeutics
Medtronic has announced its intent to acquire medical technology firm SPR Therapeutics for an upfront cash payment of approximately $650 million. The deal will integrate a short-term, minimally invasive peripheral nerve stimulation system into Medtronic's neuromodulation business during the first half of its fiscal year 2027.